How Rybelsus works and why it causes side effects Rybelsus is a brand-name prescription drug containing the active ingredient semaglutide, a GLP-1 receptor agonist that has 94% structural similarity to the naturally occurring human glucagon-like peptide-1 hormone
While these medications have an established safety profile, individual responses vary, and pre-existing gastrointestinal conditions may be unmasked or exacerbated during treatment
Your altRx membership includes telehealth consultations with a licensed provider, a personalized care plan, prescription fulfillment if appropriate, and shipping
Treatment of type 2 version of diabetes mellitus: for a start, initial dosage strength is offered at 2.5 mg offered subcutaneously as a single dose each week
To find your states program name and member services number, see what Medicaid is called in every state